OTEZLA (apremilast) tablets

OTEZLA is a prescription medicine used to treat arthritis. FDA approved tezacaftor/ivacaftor (brand name OTEZLA) is not (yet) registered or available in India but on request Indian patient can buy OTEZLA at the lowest price.

OTEZLA-apremilast-Price-Delhi-India
OTEZLA (apremilast) tablets

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

OTEZLA (apremilast) tablets

Apremilast, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4).

OTEZLA, an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of:
• Adult patients with active psoriatic arthritis
• Adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy
• Adult patients with oral ulcers associated with Behçet’s Disease

Apremilast, sold under the brand name Otezla among others, is a medication for the treatment of certain types of psoriasis and psoriatic arthritis. The drug acts as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4).

OTEZLA (apremilast) tablets, for oral use Initial U.S. Approval: 2014
—————-
Current Indication: Treat Adult patients with active psoriatic arthritis, Adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy, Adult patients with oral ulcers associated with Behçet’s Disease
—————-
Marketed By: Amgen Inc
—————-
Approval Date: : 2014
—————-
Active ingredient: apremilast
—————-

Tablets: 10 mg, 20 mg, 30 mg

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.